Certifications
American Board of Internal Medicine (Hematology)
American Board of Internal Medicine (Medical Oncology) (Certification Date: 11-01-2017 )
Clinical Interests
Hematology
Hematology and Oncology
Leukemia
Malignant Melanoma
Oncology
Acute Lymphocytic Leukemia
Bone Marrow Cancers
Cancer
Myeloma
Myelodysplastic Syndrome
Myeloproliferative Disorder
Specialities
Internal Medicine
Publications
Peer Reviewed Publications
Zayad, Anas; Ahmed, Nausheen; Mahmoudjafari, Zahra; Skikne, Barry S; Lin, Tara; Mushtaq, Muhammad U; McGuirk, Joseph; Lutfi, Forat; Bhurtel, Evguenia; Bhutani, Manisha; Anwar, Faiz; Alkharabsheh, Omar; Shebli, Atrash; Abdallah, Al-Ola (2025. ) The Impact of Sponsors on Development of Clinical Research in Multiple Myeloma and AL Amyloidosis: An In-Depth Analysis.Clinical lymphoma, myeloma & leukemia, , 25 (8 ) ,e600-e603 More Information
Mewawalla, Prerna; Dileo, Rachel; Yin, Yue; Strouse, Christopher; Shaikh, Hira; Davis, James A; Alkharabsheh, Omar; Rashid, Aliya; Ahmed, Nausheen; Abdallah, Al-Ola; Hashmi, Hamza (2025. ) Real-World Outcomes of Sequential BCMA-directed therapies in Relapsed Refractory Multiple Myeloma After Belantamab Exposure.Clinical lymphoma, myeloma & leukemia, , More Information
Dileo, Rachel; Mewawalla, Prerna; Babu, Kalaivani; Yin, Yue; Strouse, Christopher; Chen, Ethan; Shaikh, Hira; Davis, James A; Green, Kimberly M; Alkharabsheh, Omar; Rashid, Aliya; Pokhrel, Bidushi; Ahmed, Nausheen; Abdallah, Al-Ola; Hashmi, Hamza (2025. ) A real-world experience of efficacy and safety of belantamab mafodotin in relapsed refractory multiple myeloma.Blood cancer journal, , 15 (1 ) ,34 More Information
Atallah, Rawan; Ahmed, Nausheen; Ayoobkhan, Fathima; Saif, Md Saiful Islam; Logan, Emerson; Shrestha, Anuj; Anwer, Faiz; Mahmoudjafari, Zahra; Mushtaq, Muhammed Umair; Hashmi, Hamza; Ganguly, Siddhartha; McGuirk, Joseph; Shebli, Atrash; Abdallah, Al-Ola; Banerjee, Rahul; Alkharabsheh, Omar (2024. ) TACTUM: Trends in Access to Cellular Therapies in Multiple Myeloma, Perspectives of Treating Versus Referring Physicians.Transplantation and cellular therapy, , 30 (9 ) ,925.e1-925.e6 More Information
Afrough, Aimaz; Atrash, Shebli; Paul, Barry; Ouchveridze, Evguenia; Ahmed, Nausheen; Mahmoudjafari, Zahra; Bashir, Anam; Alkharabsheh, Omar; Hashmi, Hamza; Abdallah, Al-Ola (2023. ) Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab-Naïve Relapsed Multiple Myeloma.Cancers, , 15 (19 ) , More Information
Manne, Ashish; Mulekar, Madhuri; Escobar, Daisy; Prodduturvar, Pranitha; Fahmawi, Yazan; Henderson, Phillip; Abdul-Rahim, Osama; Hussain, Zeiad; Liles, Spencer; Fonseca, Annabelle; Howard, John Harrison; Mneimneh, Wadad; Gilbert, Robert; Alkharabsheh, Omar; Pai, Sachin; White, Zachary B; Nelson, Cindy; Khushman, Moh'd (2023. ) The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.Journal of cancer research and therapeutics, , 19 (5 ) ,1103-1108 More Information
Abdallah, Al-Ola; Mahmoudjafari, Zahra; Ahmed, Nausheen; Cui, Wei; Shune, Leyla; McGuirk, Joseph; Mohan, Meera; Mohyuddin, Ghulam Rehman; Afrough, Aimaz; Alkharabsheh, Omar; Atrash, Shebli (2023. ) Clinical efficacy of retreatment of daratumumab-based therapy (D2) in daratumumab-refractory multiple myeloma.European journal of haematology, , 110 (6 ) ,626-632 More Information
Atrash, Shebli; Mammadzadeh, Aytaj; Peng, Fulei; Alkharabsheh, Omar; Afrough, Aimaz; Cui, Wei; Mahmoudjafari, Zahra; Abdallah, Al-Ola; Hashmi, Hamza (2023. ) Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy.Cancers, , 15 (11 ) , More Information
Alkharabsheh, Omar; Bellman, Polina; Mahmoudjafari, Zahra; Cui, Wei; Atrash, Shebli; Paul, Barry; Hashmi, Hamza; Shune, Leyla; Ahmed, Nausheen; Abdallah, Al-Ola (2023. ) Adverse Hematological and Non-Hematological Events in Patients With Relapsed/Refractory Multiple Myeloma That Are Responsive to Daratumumab, Pomalidomide and Dexamethasone.Journal of hematology, , 12 (1 ) ,1-6 More Information
Njomen, Evert; Vanecek, Allison; Lansdell, Theresa A; Yang, Ya-Ting; Schall, Peter Z; Harris, Christi M; Bernard, Matthew P; Isaac, Daniel; Alkharabsheh, Omar; Al-Janadi, Anas; Giletto, Matthew B; Ellsworth, Edmund; Taylor, Catherine; Tang, Terence; Lau, Sarah; Bailie, Marc; Bernard, Jamie J; Yuzbasiyan-Gurkan, Vilma; Tepe, Jetze J (2022. ) Small Molecule 20S Proteasome Enhancer Regulates MYC Protein Stability and Exhibits Antitumor Activity in Multiple Myeloma.Biomedicines, , 10 (5 ) , More Information
Alkharabsheh, Omar; Trisel, Zachary; Badami, Sunil; Aljama, Mohammed A; Sidiqi, M Hasib (2021. ) Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises.Cancers, , 14 (1 ) , More Information
Khushman, Moh'd; Prodduturvar, Pranitha; Mneimneh, Wadad; Zotto, Valeria Dal; Akbar, Shalla; Grimm, Leander; Rider, Paul; Hunter, John; Alkharabsheh, Omar; Patel, Girijesh Kumar; Fabregas, Jesus C; Singh, Ajay P (2021. ) The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma.Oncotarget, , 12 (15 ) ,1490-1498 More Information
Manne, Ashish; Mulekar, Madhuri S; Escobar, Daisy E; Alsayed, Alhareth; Sharma, Gaurav; Prodduturvar, Pranitha; Khushman, Moh'd; Howard, John Harrison; Gilbert, Robert; Alkharabsheh, Omar (2021. ) Clinical and Hematological Predictors of High-Grade Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors.Journal of clinical medicine research, , 13 (5 ) ,268-275 More Information
Alkharabsheh, Omar; Alsayed, Alhareth; Morlote, Diana M; Mehta, Amitkumar (2021. ) Cerebral Invasive Aspergillosis in a Case of Chronic Lymphocytic Leukemia with Bruton Tyrosine Kinase Inhibitor.Current oncology (Toronto, Ont.), , 28 (1 ) ,837-841 More Information
Fahmawi, Yazan; Smith, Clayton; Grimm, Leander; Khullar, Shikha; Rider, Paul; Hunter, John; Iliff, Greire; Mneimneh, Wadad; Roveda, Kelly; Wang, Bin; Prodduturvar, Pranitha; Alkharabsheh, Omar; McCormick, Ben; Mizrahi, Meir; Khushman, Moh'd (2020. ) Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.Clinical colorectal cancer, , 19 (4 ) ,e281-e287 More Information
Alkharabsheh, Omar; Patnaik, Mrinal M; Gangat, Naseema; Begna, Kebede H; Alkhateeb, Hassan B; Shah, Mithun Vinod; Hogan, William J; He, Rong; Greipp, Patricia; Nguyen, Phuong L; Litzow, Mark R; Al-Kali, Aref (2020. ) Impact of marrow blasts percentage on high-grade myelodysplastic syndrome assessed using revised international prognostic scoring system.Annals of hematology, , 99 (3 ) ,513-518 More Information
Alkharabsheh, Omar; Sidiqi, M Hasib; Aljama, Mohammed A; Gertz, Morie A; Frankel, Arthur E (2020. ) The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors.Acta haematologica, , 143 (2 ) ,118-123 More Information
Fahmawi, Yazan; Campos, Yesica; Khushman, Moh'd; Alkharabsheh, Omar; Manne, Ashish; Zubair, Haseeb; Haleema, Saadia; Polski, Jacek; Bessette, Sabrina (2019. ) Vitamin B12 deficiency presenting as pseudo-thrombotic microangiopathy: a case report and literature review.Clinical pharmacology : advances and applications, , 11 ,127-131 More Information
Alkharabsheh, Omar A; Saadeh, Salwa S; Zblewski, Darci L; Gangat, Naseema; Begna, Kebede H; Elliott, Michelle A; Alkhateeb, Hassan B; Patnaik, Mrinal S; Hogan, William J; Litzow, Mark R; Al-Kali, Aref (2019. ) Frequency of venous thrombotic events in patients with myelodysplastic syndrome and 5q deletion syndrome during lenalidomide therapy.Annals of hematology, , 98 (2 ) ,331-337 More Information
Alkharabsheh, Omar; Frankel, Arthur E (2019. ) Clinical Activity and Tolerability of SL-401 (Tagraxofusp): Recombinant Diphtheria Toxin and Interleukin-3 in Hematologic Malignancies.Biomedicines, , 7 (1 ) , More Information
Alkharabsheh, Omar; Saadeh, Salwa S; Patnaik, Mrinal S; Alkhateeb, Hassan; Gangat, Naseema; Begna, Kebede H; Hogan, William J; Greipp, Patricia T; He, Rong; Nguyen, Phuong L; Litzow, Mark R; Al-Kali, Aref (2018. ) Impact of clone size with a single cytogenetic abnormality on the revised International Prognostic Scoring System in myelodysplastic syndromes.American journal of hematology, , 93 (12 ) ,E398-E401 More Information
Alkharabsheh, Omar; Al-Kali, Aref; Saadeh, Salwa; He, Rong; Viswanatha, David; Greipp, Patricia; Reichard, Kaaren; Shah, Mithun; Gangat, Naseema; Patnaik, Mrinal; Hogan, William; Litzow, Mark; Alkhateeb, Hassan; Nguyen, Phuong L (2018. ) The clinical outcomes of reclassified erythroleukemia (erythroid/myeloid) as myelodysplastic syndrome (MDS) per 2017 WHO guideline compared to MDS.American journal of hematology, , 93 (11 ) ,E355-E357 More Information
Alkharabsheh, Omar; Kannarkatt, Paul; Kannarkatt, Joseph; Karapetyan, Lilit; Laird-Fick, Heather S; Al-Janadi, Anas (2018. ) An overview of the toxicities of checkpoint inhibitors in older patients with cancer.Journal of geriatric oncology, , 9 (5 ) ,451-458 More Information
Kannarkatt, Joseph; Alkharabsheh, Omar; Tokala, Hemasri; Dimitrov, Nikolay V (2016. ) Metformin and Angiogenesis in Cancer - Revisited.Oncology, , 91 (4 ) ,179-184 More Information